These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7031245)

  • 21. [Outbreak of shigellosis among non-human primates maintained in captivity].
    Brito Loureiro EC; Amorim Carvalho R
    Rev Latinoam Microbiol; 1984; 26(4):305-8. PubMed ID: 6522874
    [No Abstract]   [Full Text] [Related]  

  • 22. Quarantine of vervet monkeys.
    Chernyshov VI
    Primates Med; 1969; 3(0):124-8. PubMed ID: 5006025
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathologic study of a rabbit model for shigellosis.
    Etheridge ME; Hoque AT; Sack DA
    Lab Anim Sci; 1996 Feb; 46(1):61-6. PubMed ID: 8699822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experiences in quarantine of imported monkeys.
    Tokura H; Matsubayashi K
    Jikken Dobutsu; 1973; 22 Suppl(0):443-6. PubMed ID: 4214310
    [No Abstract]   [Full Text] [Related]  

  • 25. "Intestinal spirochaetosis" of the vervet monkey.
    Cowley HM; Hill RR
    Onderstepoort J Vet Res; 1985 Mar; 52(1):47-50. PubMed ID: 3925404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriological and epidemiological approach to prophylaxy for enteric infection. IV. Experimental bladder infection of Shigella.
    Anzai H; Kubota Y; Okamoto M; Sekizuka S; Nakamura T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):155-66. PubMed ID: 4949632
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gena types of Shigella enterotoxins of S. flexneri 2a].
    Bai S; Li X; Xia G; Yuan H; Zheng W; Wang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):280-2. PubMed ID: 11860800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonenteric Shigella infections in nonhuman primates.
    McClure HM; Alford P; Swenson B
    J Am Vet Med Assoc; 1976 Nov; 169(9):938-9. PubMed ID: 824262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Toxic food infection caused by Shigella flexneri in a military unit].
    Cheftel E; Spiegel A; Bornert G; Morell E; Michel A; Buisson Y
    Sante; 1997; 7(5):295-9. PubMed ID: 9480034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infections caused by Shigella flexneri recognized as food poisonings in Warmia and Mazury Voivodeship].
    Sokołowska M; Ulatowska-Bogdan W; Tunowska M; Dziedziech M; Dzisko J
    Przegl Epidemiol; 2005; 59(1):53-8. PubMed ID: 16013410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphologic characterization of the contemporary dysentery caused by Shigella flexneri 2A].
    Tsinzerling VA; Komarova DV; Vasin IuV
    Arkh Patol; 1997; 59(1):41-5. PubMed ID: 9139607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks associated with environmental enrichment: intestinal obstruction caused by foraging substrate.
    Seier JV; Dhansay MA; Davids A
    J Med Primatol; 2005 Jun; 34(3):154-5. PubMed ID: 15860124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriological and epidemiological approach to prophylaxis for enteric infection. Effects of peritoneal cells from immunized animals on the infectivity of Shigella bacillus to HeLa cells.
    Sakaguchi T; Sakaguchi S
    Kitasato Arch Exp Med; 1981 Dec; 54(3-4):41-7. PubMed ID: 6759764
    [No Abstract]   [Full Text] [Related]  

  • 35. The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions.
    Katakura S; Reinholt FP; Kärnell A; Huan PT; Trach DD; Lindberg AA
    APMIS; 1990 Apr; 98(4):313-9. PubMed ID: 2191692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Shigella flexneri diarrhoea with positive blood culture].
    Taieb B; Ghnassia JC; Berche P; Hennequet A
    Ann Pediatr (Paris); 1978; 25(5-6):266-8. PubMed ID: 16114334
    [No Abstract]   [Full Text] [Related]  

  • 40. Serotype distribution and antimicrobial susceptibility of Shigellae isolated from diarrhoeal patients in Yangon, Myanmar.
    Oo KN; Thida M
    J Diarrhoeal Dis Res; 1995 Sep; 13(3):180-2. PubMed ID: 8568195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.